About the Authors
- Dennis M. Lindell
-
Affiliation Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, United States of America
- Susan B. Morris
-
Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
- Maria P. White
-
Affiliation Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, Washington, United States of America
- Lara E. Kallal
-
Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
- Phillip K. Lundy
-
Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
- Tarek Hamouda
-
Affiliation NanoBio Corporation, Ann Arbor, Michigan, United States of America
- James R. Baker Jr
-
Affiliation Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan, United States of America
- Nicholas W. Lukacs
-
* E-mail: nlukacs@umich.edu
Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Competing Interests
Tarek Hamouda and James Baker, Jr., are employed by or have financial interest in NanoBio Corporation, which developed the adjuvant used in this manuscript and associated patents for use of the Nanoemulsion for use in vaccines. The other authors are employed solely by the University of Michigan or Seattle Children's Hospital and have no employment affiliation with NanoBio. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DML TH JRB NWL. Performed the experiments: DML SBM MPW LEK PKL NWL. Contributed reagents/materials/analysis tools: TK JRB. Wrote the paper: DML JRB NWL.